Celldex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. 

CEO
Anthony S. Marucci
CEOAnthony S. Marucci
Employees
186
Employees186
Headquarters
Hampton, New Jersey
HeadquartersHampton, New Jersey
Founded
1983
Founded1983
Employees
186
Employees186

CLDX Key Statistics

Market cap
1.66B
Market cap1.66B
Price-Earnings ratio
-7.34
Price-Earnings ratio-7.34
Dividend yield
Dividend yield
Average volume
631.93K
Average volume631.93K
High today
$25.24
High today$25.24
Low today
$24.46
Low today$24.46
Open price
$24.72
Open price$24.72
Volume
89.40K
Volume89.40K
52 Week high
$30.50
52 Week high$30.50
52 Week low
$14.40
52 Week low$14.40

Stock Snapshot

Celldex(CLDX) stock is priced at $24.98, giving the company a market capitalization of 1.66B. It carries a P/E multiple of -7.34.

As of 2026-02-10, Celldex(CLDX) stock has fluctuated between $24.46 and $25.24. The current price stands at $24.98, placing the stock +2.1% above today's low and -1.0% off the high.

The Celldex(CLDX)'s current trading volume is 89.4K, compared to an average daily volume of 631.93K.

In the last year, Celldex(CLDX) shares hit a 52-week high of $30.50 and a 52-week low of $14.40.

In the last year, Celldex(CLDX) shares hit a 52-week high of $30.50 and a 52-week low of $14.40.

CLDX News

Nasdaq 5d
Celldex Therapeutics Breaks Below 200-Day Moving Average - Notable for CLDX

In trading on Thursday, shares of Celldex Therapeutics, Inc. (Symbol: CLDX) crossed below their 200 day moving average of $23.76, changing hands as low as $23.6...

Celldex Therapeutics Breaks Below 200-Day Moving Average - Notable for CLDX
Simply Wall St 7d
Assessing Celldex Therapeutics Valuation After Recent Share Price Momentum And Ongoing Losses

Advertisement Recent move in Celldex Therapeutics Celldex Therapeutics (CLDX) has been on many watchlists after recent trading, with the stock closing at US$2...

Assessing Celldex Therapeutics Valuation After Recent Share Price Momentum And Ongoing Losses

Analyst ratings

80%

of 15 ratings
Buy
80%
Hold
13.3%
Sell
6.7%

People also own

Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.